| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis
|
Lien, Ming-Yu
|
|
|
19 |
1 |
p. 71-79
|
article
|
| 2 |
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)
|
Wang, Hung-Ming
|
|
|
19 |
1 |
p. 51-58
|
article
|
| 3 |
Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
|
Fung, Simon
|
|
|
19 |
1 |
p. 129
|
article
|
| 4 |
Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non‑Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
|
Le, Xiuning
|
|
|
19 |
1 |
p. 125
|
article
|
| 5 |
Correction to: Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis
|
Maiorano, Brigida Anna
|
|
|
19 |
1 |
p. 127
|
article
|
| 6 |
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in Korea
|
Shin, Yeokyeong
|
|
|
19 |
1 |
p. 41-49
|
article
|
| 7 |
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer
|
Sunakawa, Yu
|
|
|
19 |
1 |
p. 59-69
|
article
|
| 8 |
Ezurpimtrostat, A Palmitoyl-Protein Thioesterase-1 Inhibitor, Combined with PD-1 Inhibition Provides CD8+ Lymphocyte Repopulation in Hepatocellular Carcinoma
|
Bestion, Eloïne
|
|
|
19 |
1 |
p. 95-106
|
article
|
| 9 |
Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis
|
Maiorano, Brigida Anna
|
|
|
19 |
1 |
p. 1-11
|
article
|
| 10 |
Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors
|
Martella, Serafina
|
|
|
19 |
1 |
p. 13-28
|
article
|
| 11 |
Pemigatinib: A Review in Advanced Cholangiocarcinoma
|
Frampton, James E.
|
|
|
19 |
1 |
p. 107-114
|
article
|
| 12 |
Prognostic Impact of HER2-Low and HER2-Zero in Resectable Breast Cancer with Different Hormone Receptor Status: A Landmark Analysis of Real-World Data from the National Cancer Center of China
|
Dai, Qichen
|
|
|
19 |
1 |
p. 81-93
|
article
|
| 13 |
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma
|
Camera, Silvia
|
|
|
19 |
1 |
p. 29-39
|
article
|
| 14 |
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma
|
France, Nicole L.
|
|
|
19 |
1 |
p. 115-123
|
article
|
Journal description